6533b82afe1ef96bd128caad
RESEARCH PRODUCT
Additional file 3: Figure S1. of Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial
Christopher PapandreouMònica BullòFrancisco TinahonesMiguel Martínez-gonzálezDolores CorellaGeorgios FragkiadakisJosé López-mirandaRamon EstruchMontserrat FitóJordi Salas-salvadósubject
description
Principal component analysis (PCA) model to discriminate between the three baseline states in groups 1, 2 and 3. Model diagnostics (A = 8, R2X = 0.651, Q2X = 0.264) (DOCX 43 kb)
year | journal | country | edition | language |
---|---|---|---|---|
2017-01-01 |